What is Johnson & Johnson's darzalex — percent change (as a percent)?

Johnson & Johnson (JNJ) reported darzalex — percent change (as a percent) of 64.6% in Q3 2025.

How has Johnson & Johnson's darzalex — percent change (as a percent) changed year-over-year?

Johnson & Johnson's darzalex — percent change (as a percent) increased by 4.9% year-over-year, from 61.6% to 64.6%.

What does darzalex — percent change (as a percent) mean?

The percentage growth rate of sales for a specific drug compared to a prior period.

DARZALEX — Percent Change (as a percent)

Products & Services · Percent Change (as a percent)

Johnson & Johnson DARZALEX — Percent Change (as a percent) decreased by 6.4% to 64.6% in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 4.9%, from 61.6% to 64.6%. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment

CategoryGrowth

SignalHigher is better

VolatilityVolatile

First reportedQ1 2018

Last reportedQ3 2025

How to read this metric

An increase suggests accelerating market adoption or expanded clinical indications, whereas a decrease may indicate market saturation or the emergence of competitive therapies.

Detailed definition

This metric measures the period-over-period percentage growth rate of net sales for a specific pharmaceutical product. I...

Peer comparison

Comparable to year-over-year or sequential growth rates for key product lines reported by peers in the biopharmaceutical industry.

Metric ID: jnj_segment_darzalex_percent_change_as_a_percent

Historical Data

14 periods

	Q2 '21	Q3 '21	Q4 '21	Q2 '22	Q3 '22	Q4 '22	Q2 '23	Q3 '23	Q1 '24	Q2 '24	Q3 '24	Q1 '25	Q2 '25	Q3 '25
Value	137%	178%	131.1%	107.9%	116.7%	89.4%	65.8%	64.9%	56.3%	54.1%	61.6%	59.9%	69%	64.6%
QoQ Change	—	+29.9%	-26.3%	-17.7%	+8.2%	-23.4%	-26.4%	-1.4%	-13.3%	-3.9%	+13.9%	-2.8%	+15.2%	-6.4%
YoY Change	—	—	—	-21.2%	-34.4%	-31.8%	-39.0%	-44.4%	—	-17.8%	-5.1%	+6.4%	+27.5%	+4.9%

Range54.1% – 178%

CAGR-20.7%

Avg YoY Growth-15.5%

Median YoY Growth-19.5%

Similar Metrics at Other Companies

Eli LillyLLY View metric

Frequently Asked Questions

What is Johnson & Johnson's darzalex — percent change (as a percent)?: Johnson & Johnson (JNJ) reported darzalex — percent change (as a percent) of 64.6% in Q3 2025.
How has Johnson & Johnson's darzalex — percent change (as a percent) changed year-over-year?: Johnson & Johnson's darzalex — percent change (as a percent) increased by 4.9% year-over-year, from 61.6% to 64.6%.
What does darzalex — percent change (as a percent) mean?: The percentage growth rate of sales for a specific drug compared to a prior period.